#header #header-bottom .menu-wrapper{display: block!important;}

Attention javascript est désactivé sur votre poste.
Ce site nécessite l'activation de javascript pour fonctionner correctement.

AACR April, 2016 – Enhanced antitumor activity achieved by combining the oncolytic peptide LTX-315 with anti-PD-L1 antibody

Home . Resources . AACR April, 2016 - Enhanced antitumor activity achieved by combining the oncolytic peptide LTX-315 with anti-PD-L1 antibody

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Receive our general news!